Recombinant Human monoclonal antibody expressed in CHO binding to Human CXCL13. VX5 is a monoclonal antibody that specifically binds human, primate and rodent CXCL13, neutralizes its activity and exhibits therapeutic benefit in mouse models of human autoimmune diseases (such as rheumatoid arthritis and multiple sclerosis).
Figure 1 Anti-CXCL13 Antibody (TAB-200CL) in ELISA
ELISA analysis of TAB-200CL was performed by coating with recombinant human CXCL13 protein. The HRP-conjugated goat anti-mouse IgG as a secondary antibody.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2335z | Mouse Anti-CXCL13 Recombinant Antibody (clone 24G7) | WB, ELISA, FC, IHC, Neut | Mouse IgG1 |
MOB-0904MZ | Recombinant Mouse Anti-Human CXCL13 Antibody (clone NN0323-23B3) | Neut | Mouse antibody |
HPAB-0060-CN | Human Anti-CXCL13 Recombinant Antibody (clone Ab 1) | FC, ELISA, WB, IF | Human IgG1 |
There are currently no Customer reviews or questions for TAB-200CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.